Literature DB >> 2598057

D-, L- and DL-fenfluramine cause long-lasting depletions of serotonin in rat brain.

M S Kleven1, L S Seiden.   

Abstract

D-Fenfluramine (1.6-12.5 mg/kg), L-fenfluramine (1.6-25 mg/kg), and DL-fenfluramine (1.6-25 mg/kg) injected s.c. twice daily for 4 consecutive days produced dose-related depletions of serotonin (5-HT) levels in somatosensory cortex, striatum, hypothalamus, and hippocampus of rats (n = 5-8/group) sacrificed two weeks after the last injection. While the results indicate that long-lasting effects of racemic fenfluramine are due to both stereoisomers, the magnitude of depletions caused by the isomers varied with dose, suggesting that they have different neurochemical effects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2598057     DOI: 10.1016/0006-8993(89)91467-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Selective neurotoxins, chemical tools to probe the mind: the first thirty years and beyond.

Authors:  R M Kostrzewa
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

2.  Neurotoxicity and substance abuse: further fuel for regulatory dilemma.

Authors:  T Archer; T Palomo; R M Kostrzewa
Journal:  Neurotox Res       Date:  2001-01       Impact factor: 3.911

3.  Acute and chronic D-fenfluramine treatments have different effects on serotonin synthesis rates in the rat brain: an autoradiographic study.

Authors:  F Yamane; Y Tohyama; M Diksic
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

Review 4.  A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.

Authors:  L L Carpenter; C J McDougle; C N Epperson; L H Price
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

Review 5.  Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity.

Authors:  D McTavish; R C Heel
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

6.  Effect of d-fenfluramine on the indole contents of the rat brain after treatment with different inducers of cytochrome P450 isoenzymes.

Authors:  M Anelli; C Fracasso; A Bergami; A Ferrarese; S Garattini; S Caccia
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

7.  The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine.

Authors:  D B Miller; J P O'Callaghan
Journal:  Mol Neurobiol       Date:  1995 Aug-Dec       Impact factor: 5.590

8.  p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo.

Authors:  H G Series; P J Cowen; T Sharp
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

9.  In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the rat.

Authors:  T Mennini; C Fracasso; A Cagnotto; A Bergami; E Frittoli; M Gobbi; S Caccia; S Garattini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-05       Impact factor: 3.000

10.  Quantitative positron emission tomography studies of the serotonin transporter in humans previously treated with the appetite suppressants fenfluramine or dexfenfluramine.

Authors:  Una D McCann; Zsolt Szabo; Melin Vranesic; Esen Seckin; Gary Wand; Anna Duval; Robert F Dannals; George A Ricaurte
Journal:  Mol Imaging Biol       Date:  2007 May-Jun       Impact factor: 3.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.